Axsome Therapeutics, Inc. (AXSM)
Market Closed
17 Jul, 20:00
$
230. 00
-7.04
-2.97%
$
12.03B Market Cap
- P/E Ratio
- Div Yield
878,300 Volume
-4.27 Eps
$ 237.04
Previous Close 
Want to track AXSM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Axsome Therapeutics, Inc. (AXSM) Statistics
Valuation metrics
Market Cap 12.03B
Enterprise value 11.75B
Trailing P/E (ttm) -61.66
Forward P/E 29.89
PEG ratio -1.38
Price/Sales (ttm) 16.71
Price/Book (mrq) 215.72
Enterprise Value/Revenue 16.59
Enterprise Value/EBITDA -68.03
Overview
Shares outstanding 50.88M
Float 43.24M
Shares short 2.83M
% Held by insiders 0.15%
% Held by institutions 0.76%
Average volume (10 days) 722.73K
Average volume (90 days) 973.19K
Price summary
52-Week low 96.09
52-Week high 260.19
Beta 0.47
50-Day moving average 240
200-Day moving average 192.27
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.27%
Operating margin -0.25%
Operational effectiveness
Return on assets -0.26%
Return on equity -2.6%
Income Statement
Revenue (ttm) 638.5M
Revenue per share (ttm) 13.83
Quarterly revenue growth (yoy) 0.65%
Gross profit (ttm) 591.02M
EBITDA -160.17M
Net income to common (ttm) -183.17M
Diluted EPS (ttm) -3.68
Quarterly earnings growth (yoy) 0.65%
Balance Sheet
Total cash (mrq) 322.93M
Total cash per share (mrq) 5.96
Total debt (mrq) 218.11M
Total Debt/Equity (mrq) 4.03
Current ratio (mrq) 1.39%
Book value per share (mrq) 1.07
Cash Flow
Cash flow statement -93.41M
Levered free cash flow (LFCF) -29.42M
